123 related articles for article (PubMed ID: 21401572)
1. Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding.
Spectre G; Roth B; Ronen G; Rosengarten D; Elstein D; Zimran A; Varon D; Revel-Vilk S
Br J Haematol; 2011 May; 153(3):372-8. PubMed ID: 21401572
[TBL] [Abstract][Full Text] [Related]
2. Impaired platelet function and peripartum bleeding in women with Gaucher disease.
Simchen MJ; Oz R; Shenkman B; Zimran A; Elstein D; Kenet G
Thromb Haemost; 2011 Mar; 105(3):509-14. PubMed ID: 21301776
[TBL] [Abstract][Full Text] [Related]
3. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia.
Panzer S; Rieger M; Vormittag R; Eichelberger B; Dunkler D; Pabinger I
Eur J Clin Invest; 2007 Oct; 37(10):814-9. PubMed ID: 17727674
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.
Mitrovic M; Antic D; Elezovic I; Janic D; Miljic P; Sumarac Z; Nikolic T; Suvajdzic N
Platelets; 2012; 23(2):143-9. PubMed ID: 21767238
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease.
Givol N; Goldstein G; Peleg O; Shenkman B; Zimran A; Elstein D; Kenet G
Haemophilia; 2012 Jan; 18(1):117-21. PubMed ID: 21545377
[TBL] [Abstract][Full Text] [Related]
7. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[TBL] [Abstract][Full Text] [Related]
8. Coagulation abnormalities in type 1 Gaucher disease in children.
Deghady A; Marzouk I; El-Shayeb A; Wali Y
Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
[TBL] [Abstract][Full Text] [Related]
9. Platelet function defects in patients with Gaucher disease on long term ERT- implications for evaluation at bleeding challenges.
Komninaka V; Repa K; Marinakis T; Pouliakis A; Koutsouri T; Tsokanas D; Flevary P; Voskaridou E; Politou M
Blood Cells Mol Dis; 2020 Feb; 80():102371. PubMed ID: 31670186
[No Abstract] [Full Text] [Related]
10. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S; Roberts A; Patterson MA; Amato D
Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
[TBL] [Abstract][Full Text] [Related]
11. Complex haemostatic abnormalities as a cause of bleeding after neurosurgery in a patient with Gaucher disease.
Mitrovic M; Elezovic I; Grujicic D; Miljic P; Suvajdzic N
Platelets; 2015; 26(3):260-2. PubMed ID: 24749498
[TBL] [Abstract][Full Text] [Related]
12. Platelet function abnormalities in Gaucher disease patients.
Gillis S; Hyam E; Abrahamov A; Elstein D; Zimran A
Am J Hematol; 1999 Jun; 61(2):103-6. PubMed ID: 10367788
[TBL] [Abstract][Full Text] [Related]
13. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.
Hollak CE; Belmatoug N; Cole JA; Vom Dahl S; Deegan PB; Goldblatt J; Rosenbloom B; van Dussen L; Tylki-Szymańska A; Weinreb NJ; Zimran A; Cappellini MD
Br J Haematol; 2012 Aug; 158(4):528-38. PubMed ID: 22640238
[TBL] [Abstract][Full Text] [Related]
15. Use of the DiaMed Impact R to test platelet function in stored platelet concentrates.
Morrison A; Hornsey VS; Prowse CV; Macgregor IR
Vox Sang; 2007 Aug; 93(2):166-72. PubMed ID: 17683361
[TBL] [Abstract][Full Text] [Related]
16. Platelet adhesion in atrial fibrillation.
Choudhury A; Chung I; Blann A; Lip GY
Thromb Res; 2007; 120(4):623-9. PubMed ID: 17250878
[TBL] [Abstract][Full Text] [Related]
17. Platelet function changes as monitored by cone and plate(let) analyzer during beating heart surgery.
Gerrah R; Snir E; Brill A; Varon D
Heart Surg Forum; 2004; 7(3):E191-5. PubMed ID: 15262600
[TBL] [Abstract][Full Text] [Related]
18. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].
Shenkman B; Einav Y; Salomon O; Varon D; Savion N
Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of platelet function using stagnation point flow aggregometry. First clinical results.
Reininger CB; Reininger AJ; Hörmann A; Steckmeier B; Schweiberer L
Int Angiol; 1992; 11(4):247-55. PubMed ID: 1295930
[TBL] [Abstract][Full Text] [Related]
20. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
Pastores GM; Barnett NL; Kolodny EH
Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
